TY - JOUR
T1 - Factors limiting habitual exercise in patients with chronic heart failure
T2 - a multicenter prospective cohort study
AU - Tadaki, Soichiro
AU - Sakata, Yasuhiko
AU - Miura, Yutaka
AU - Nochioka, Kotaro
AU - Miura, Masanobu
AU - Miyata, Satoshi
AU - Asakura, Masanori
AU - Shimada, Kazunori
AU - Yamamoto, Takeshi
AU - Fukumoto, Yoshihiro
AU - Kadokami, Toshiaki
AU - Yasuda, Satoshi
AU - Miura, Toshiro
AU - Ando, Shin ichi
AU - Yano, Masafumi
AU - Kitakaze, Masafumi
AU - Daida, Hiroyuki
AU - Shimokawa, Hiroaki
N1 - Funding Information:
This study was supported in part by the Grants-in Aid from the Ministry of Health, Labour, and Welfare (Grant Nos. 201412015B, 201120009B, 200825012B) and the Agency for Medical Research and Development (15ek0210043h0001), Tokyo, Japan.
Funding Information:
The Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine is supported in part by unrestricted research grants from Daiichi Sankyo Co., Ltd. (Tokyo, Japan), Bayer Yakuhin, Ltd. (Osaka, Japan), Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan), Kowa Pharmaceutical Co., Ltd. (Tokyo, Japan), Novartis Pharma K.K. (Tokyo, Japan), Dainippon Sumitomo Pharma, Co., Ltd. (Osaka, Japan), Nippon Boehringer Ingelheim Co., Ltd. (Tokyo, Japan), Astellas Pharma (Tokyo, Japan), AstraZeneca (Osaka, Japan), Chugai Pharmaceutical (Tokyo, Japan), GlaxoSmithKline (Tokyo, Japan), Mitsubishi Tanabe Pharma (Osaka, Japan), Mochida Pharmaceutical (Tokyo, Japan), MSD (Tokyo, Japan), Otsuka Pharmaceutical (Tokyo, Japan), Shionogi (Osaka, Japan) and Takeda Pharmaceutical (Tokyo, Japan). H.S. has received lecture fees from Bayer Yakuhin, Ltd. (Osaka, Japan), Daiichi Sankyo Co., Ltd. (Tokyo, Japan) and Novartis Pharma K.K. (Tokyo, Japan). Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Publisher Copyright:
© 2019, Springer Japan KK, part of Springer Nature.
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Physical activity (PA) in the daily life is strongly related to prognosis in patients with or at high risk of heart failure (HF). However, factors limiting habitual exercise and their prognostic impacts remain unknown in HF patients. We sent questionnaires asking factors limiting habitual exercise in the daily life to 8370 patients with Stage A/B/C/D HF in our nationwide registry and received valid responses from 4935 patients (mean age 71.8 years, 71.0% male). Among the 5 components consisting of “busyness”, “weak will”, “dislike, “socioeconomic reasons” and “diseases” in the questionnaires, “busyness” (34.5%) and “diseases” (34.7%) were the most frequently reported factors limiting habitual exercise, while “socioeconomic reasons” were the least (15.3%). Multiple Cox proportional hazard models indicated that “busyness”and “diseases” were associated with better (hazard ratio (HR) 0.53, 95% confidence interval (CI) 0.39–0.72, P < 0.001) and worse prognosis (HR 1.57, 95% CI 1.21–1.98, P < 0.001), respectively, while other components were not. Furthermore, it was noted that, while prognostic relevance of “busyness” limiting exercise did not differ by age or sex, negative impact of “diseases” was particularly evident in patients with age < 75 years (P for interaction < 0.01). Factors limiting habitual exercise were associated with “busyness” and “diseases”, but not with “weak will”, “dislike, or “socioeconomic reasons”. While “busyness” was associated with better prognosis regardless of age and sex, “diseases” was associated with worse prognosis in younger populations. Thus, physicians may pay more attentions to the reasons that limit exercise in the daily lives of HF patients rather than the low amount of exercise itself.
AB - Physical activity (PA) in the daily life is strongly related to prognosis in patients with or at high risk of heart failure (HF). However, factors limiting habitual exercise and their prognostic impacts remain unknown in HF patients. We sent questionnaires asking factors limiting habitual exercise in the daily life to 8370 patients with Stage A/B/C/D HF in our nationwide registry and received valid responses from 4935 patients (mean age 71.8 years, 71.0% male). Among the 5 components consisting of “busyness”, “weak will”, “dislike, “socioeconomic reasons” and “diseases” in the questionnaires, “busyness” (34.5%) and “diseases” (34.7%) were the most frequently reported factors limiting habitual exercise, while “socioeconomic reasons” were the least (15.3%). Multiple Cox proportional hazard models indicated that “busyness”and “diseases” were associated with better (hazard ratio (HR) 0.53, 95% confidence interval (CI) 0.39–0.72, P < 0.001) and worse prognosis (HR 1.57, 95% CI 1.21–1.98, P < 0.001), respectively, while other components were not. Furthermore, it was noted that, while prognostic relevance of “busyness” limiting exercise did not differ by age or sex, negative impact of “diseases” was particularly evident in patients with age < 75 years (P for interaction < 0.01). Factors limiting habitual exercise were associated with “busyness” and “diseases”, but not with “weak will”, “dislike, or “socioeconomic reasons”. While “busyness” was associated with better prognosis regardless of age and sex, “diseases” was associated with worse prognosis in younger populations. Thus, physicians may pay more attentions to the reasons that limit exercise in the daily lives of HF patients rather than the low amount of exercise itself.
KW - Busyness
KW - Chronic heart failure
KW - Diseases
KW - Exercise
KW - Physical activity
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=85074758059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074758059&partnerID=8YFLogxK
U2 - 10.1007/s00380-019-01529-4
DO - 10.1007/s00380-019-01529-4
M3 - Article
C2 - 31686125
AN - SCOPUS:85074758059
SN - 0910-8327
VL - 35
SP - 655
EP - 664
JO - Heart and Vessels
JF - Heart and Vessels
IS - 5
ER -